Grove Collaborative (NYSE: GROV) faces NYSE compliance deadline after listing notice
Rhea-AI Filing Summary
Grove Collaborative Holdings, Inc. reported that on August 7, 2026 it received a notice from the New York Stock Exchange stating that it is not in compliance with Section 802.01B of the NYSE Listed Company Manual, which requires an average global market capitalization of at least $50 million over a consecutive 30 trading-day period and stockholders’ equity of at least $50 million. The company must submit a business plan within 45 days showing how it expects to regain compliance within a nine‑month Cure Period. The notice has no immediate impact on the listing of Grove’s Class A common stock, and the shares are expected to continue trading on the NYSE while the company prepares and submits its plan, subject to ongoing compliance with other NYSE continued listing standards. If Grove does not submit an acceptable plan, the NYSE could initiate delisting proceedings.
Positive
- None.
Negative
- NYSE non-compliance and delisting risk: Grove received an NYSE notice for failing the $50 million market capitalization and stockholders’ equity standards, and could face potential delisting if it does not submit and execute an acceptable compliance plan within the Cure Period.
Filing Explained
The NYSE will review Grove’s business plan and decide within 45 days of receiving it whether the company reasonably demonstrates a path back to compliance; continued NYSE trading during the nine-month cure period depends on plan acceptance and compliance with other listing requirements.
8-K Event Classification
3 items: 3.01, 7.01, 9.01
3 items
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice or transferred its listing to a different exchange.
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Market cap requirement: $50 million average global market capitalization
Stockholders’ equity requirement: $50 million stockholders’ equity
Market cap averaging period: 30 trading-day period
+4 more
7 metrics
Market cap requirement
$50 million average global market capitalization
Minimum required over a consecutive 30 trading-day period under NYSE Section 802.01B
Stockholders’ equity requirement
$50 million stockholders’ equity
Minimum stockholders’ equity required under NYSE Section 802.01B
Market cap averaging period
30 trading-day period
Period over which average global market capitalization is measured
Plan submission deadline
45 days
Time from NYSE Notice for Grove to submit business plan to regain compliance
Cure Period
nine months
Period after NYSE Notice during which Grove must return to compliance
NYSE plan review window
45 days
Time for NYSE to review Grove’s submitted plan and assess its adequacy
Notice date
August 7, 2026
Date Grove received NYSE non-compliance notice
Key Terms
average global market capitalization, stockholders’ equity, continued listing standard, Cure Period, +1 more
5 terms
average global market capitalization financial
"requires an average global market capitalization of not less than $50 million"
The average global market capitalization is the mean size of publicly traded companies when you add up each company’s market value (share price times shares outstanding) across countries and divide by the number of companies measured. Think of it like the average weight of fruit in a worldwide basket: it gives investors a quick sense of whether the market is dominated by a few very large companies or by many smaller ones, which affects portfolio risk, diversification and how sensitive markets may be to moves by big firms.
stockholders’ equity financial
"and stockholders’ equity of not less than $50 million"
Stockholders’ equity is the portion of a company’s value that belongs to its owners after subtracting what the company owes from what it owns — like the equity in a house after paying the mortgage. For investors it shows the company’s net worth and can indicate financial strength, a cushion against losses, and the amount potentially available to support dividends or reinvestment; tracking changes helps assess whether the business is building or eroding owner value.
continued listing standard regulatory
"return to compliance with this continued listing standard within nine months"
Continued listing standards are the ongoing rules a stock exchange or trading venue requires a company to meet to keep its shares listed, such as minimum share price, market value, shareholder equity, and timely financial reporting. For investors, these standards matter because failure to meet them can trigger warnings or removal from the exchange, which can reduce a stock’s visibility, trading liquidity, and value—similar to how failing building inspections can limit a business’s ability to operate publicly.
Cure Period regulatory
"expects to return to compliance with this continued listing standard within nine months of receipt of the NYSE Notice (the “Cure Period”)"
A cure period is a set amount of time given to a borrower, counterparty, or contracting party to fix a missed payment, breach, or other problem before more serious consequences—like penalties, higher interest, or contract termination—kick in. For investors, it matters because it creates a short grace window that can prevent immediate losses and influence the timing and likelihood of recovery; think of it like a few extra days to pay a bill before a service is cut off.
Public Benefit Corporation regulatory
"As a B Corp and Public Benefit Corporation, Grove goes beyond selling products"
A public benefit corporation is a legal type of company that pledges to pursue a specific public good—such as environmental protection, worker welfare or community development—alongside earning profits for shareholders. Like a restaurant that promises to source local ingredients while still trying to turn a profit, this structure lets managers weigh social goals against financial returns, which can influence strategy, risk profile and investor expectations about how decisions are made.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What NYSE listing standard did Grove Collaborative (GROV) fail to meet?
Grove Collaborative failed to meet the NYSE requirement for an average global market capitalization of at least $50 million over 30 trading days and stockholders’ equity of at least $50 million, triggering a continued listing standards notice.
Does the NYSE notice immediately affect trading of GROV stock?
The notice has no immediate impact on trading of GROV’s Class A common stock. Shares are expected to continue listing on the NYSE while Grove prepares and submits its compliance plan and remains subject to other continued listing standards.
How long does Grove Collaborative (GROV) have to regain NYSE compliance?
Grove must submit a business plan within 45 days showing how it expects to regain compliance within a nine‑month Cure Period. The NYSE will review the plan and decide whether Grove has reasonably demonstrated an ability to meet the standards.
What happens if Grove Collaborative (GROV) fails to submit or execute its NYSE plan?
If Grove does not submit a plan on time or the NYSE does not accept it, the exchange could initiate delisting proceedings. Continued listing during the Cure Period also depends on Grove meeting other NYSE standards and demonstrating progress.
What are the key financial thresholds in Grove’s NYSE continued listing issue?
The NYSE notice cites failure to meet Section 802.01B, which requires an average global market capitalization of at least $50 million over 30 trading days and stockholders’ equity of at least $50 million to maintain listing.
When did Grove Collaborative (GROV) receive the NYSE non-compliance notice?
Grove received the NYSE non-compliance notice on August 7, 2026. The company later issued a press release on August 11, 2026 describing the notice, the Cure Period, and its intention to submit a plan to regain compliance.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 7, 2026
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||
(800 ) 231-8527
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On August 7, 2026, Grove Collaborative Holdings, Inc. (the “Company”) received notice from the New York Stock Exchange (the “NYSE”) that it is not in compliance with the requirement of Section 802.01B of the New York Stock Exchange Listed Company Manual (the “NYSE Manual”) that the Company have an average market capitalization of not less than $50.0 million over a consecutive 30 trading-day period and stockholders’ equity of not less than $50.0 million (the “NYSE Notice”).
Pursuant to the NYSE Notice, the Company is subject to the procedures set forth in Sections 801 and 802 of the NYSE Manual and must submit a business plan within 45 days of receipt of the NYSE Notice that demonstrates how the Company expects to return to compliance with this continued listing standard within nine months of receipt of the NYSE Notice.
The notice and procedures described above have no effect on the listing of the Company’s securities at this time, subject to the Company’s compliance with other continued listing requirements, and the Company intends to submit a plan to regain compliance as required by the rules of the NYSE and as set forth in the NYSE Notice.
Item 7.01 Regulation FD Disclosure
On August 11, 2026, the Company issued a press release related to the NYSE Notice as described above in Item 3.01 of this Current Report on Form 8-K. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
In accordance with General Instruction B.2 of Form 8-K, the information contained or incorporated in this Item 7.01, including the press release furnished herewith as Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | |||||||||||||||||||||||||
| 99.1 | Press Release dated August 11, 2026 | |||||||||||||||||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL) | |||||||||||||||||||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GROVE COLLABORATIVE HOLDINGS, INC. | ||||||||||||||||||||||||||||||||
| By: | /s/ Scott Giesler | |||||||||||||||||||||||||||||||
| Name: | Scott Giesler | |||||||||||||||||||||||||||||||
| Title: | General Counsel and Secretary | |||||||||||||||||||||||||||||||
Date: August 11, 2026
Exhibit 99.1
Grove Receives NYSE Continued Listing Standards Notice
SAN FRANCISCO, CA — August 11, 2026 — Grove Collaborative Holdings, Inc. (NYSE: GROV) (“Grove” or “the Company”), reports that, on August 7, 2026, it received written notice (the “NYSE Notice”) from the New York Stock Exchange (“NYSE”) of non-compliance with Section 802.01B of the NYSE Listed Company Manual (the “NYSE Manual”), which requires an average global market capitalization of not less than $50 million over a consecutive 30 trading-day period and stockholders’ equity of not less than $50 million.
Pursuant to the NYSE Notice, the Company is subject to the procedures set forth in Sections 801 and 802 of the NYSE Manual and must submit a business plan within 45 days of receipt of the NYSE Notice that demonstrates how the Company expects to return to compliance with this continued listing standard within nine months of receipt of the NYSE Notice (the “Cure Period”). Pursuant to applicable NYSE rules, the NYSE will review the plan and, within 45 days of its receipt, determine whether the Company has made a reasonable demonstration of an ability to conform to the relevant standards in the Cure Period.
The NYSE Notice has no immediate impact on the listing of the Company’s Class A common stock. If the NYSE accepts the plan, the Company’s Class A common stock will continue to be listed and traded on the NYSE during the Cure Period, subject to the Company’s compliance with the other continued listing standards of the NYSE and continued periodic review by the NYSE of the Company’s progress with respect to its plan. If the plan is not submitted on a timely basis or is not accepted by the NYSE, the NYSE could initiate delisting proceedings.
About Grove Collaborative Holdings, Inc.
Grove Collaborative Holdings, Inc. (NYSE: GROV) is the one-stop online destination for everyday essentials that create a healthier home and planet. Explore thousands of thoughtfully vetted products for every room and everyone in your home, including household cleaning, personal care, health and wellness, laundry, clean beauty, kitchen, pantry, kids, baby, pet care, and beyond. Everything Grove sells meets a higher standard — from health to sustainability and performance — so you get a great value without compromising your values. As a B Corp and
Public Benefit Corporation, Grove goes beyond selling products: every order is carbon neutral, supports plastic waste cleanup initiatives, and lets you see and track the positive impact of your choices. Shopping with purpose starts at Grove.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Report that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements relating to the Company’s plan to notify the NYSE of its intent to cure the continued listing requirement deficiencies and any potential plans to cure the deficiencies and the Company’s ability to return to and maintain compliance with the NYSE continued listing standards. These forward-looking statements are based on management's current expectations. Actual results could differ from those projected in any forward-looking statements due to several risk factors, including those factors discussed under the caption "Risk Factors" in the Company’s Annual Report on Form 10-Q for the quarter ended June 30, 2026, and its other filings with the U.S. Securities and Exchange Commission. Actual results could differ materially from those indicated by the forward-looking statements. Any forward-looking statement represents management's views as of the date of this press release and the Company undertakes no duty to update these forward-looking statements, whether as a result of new information, the occurrence of future events, or otherwise, unless required by law.
Investor Relations Contact
ir@grove.co
Media Relations Contact
pr@grove.co
Source: Grove Collaborative Holdings, Inc.